摘要
目的:探讨分析早期血浆置换联合血液滤过治疗高脂血症性胰腺炎(HLAP)的临床疗效。方法:选取2009年1月至2012年12月间为院急诊科收治的HLAP患者23例作为研究对象,将其随机分为实验组(9例)和对照组(14例),为对照组患者进行CVVH治疗。为实验组患者进行HP+CVVH治疗。经过一段时间的治疗,观察对比两组患者治疗前后甘油三酯(TG)、尿素氮(BUN)及APACHEⅡ的评分,并将对比的结果及两组患者的临床资料进行回顾性的分析。结果:两组患者的各项指标较治疗前均有明显下降,差异显著(P<0.05),具有统计学意义。实验组患者的各项指标明显优于对照组患者,差异显著(P<0.05),具有统计学意义。结论:早期血浆置换联合血液滤过治疗高脂血症性胰腺炎的临床疗效显著,值得在临床上推广应用。
Objective This study was designed to evaluate the effect of earlier plasmapheresis combined with CVVH in treatment of HLAP.Methods From January 2009 to December 2012,23 patients of HLAP were admitted to the study,and were divided into 2 groups: the treatment group were carried out with HP +CVVH,while the control group just CVVH. Serum triglyceride(TG),urea nitrogen(BUN)and APACHEⅡscore were compaired respectedly.SAS8.0 software was used for statistical analysis, P <0.05 was considered statistically significant.Results After treatment, TG 、BUN and APACHEⅡscore were decreased in both group,but decreased more distinctly in the treatment group(P<0.05).Conclusion Compared with CVVH, HP+CVVH can more distinctly improve physical conditions,prevent the complications,and the therapeutic effect was better.
出处
《求医问药（下半月）》
2013年第12期111-112,共2页
Seek Medical and Ask The Medicine
